They utilized an E. coli system, previously developed by the Etherno team (iGEM HKU Hong Kong, 2018), that is capable of producing two specific DNA nanostructures for targeting an epithelial cell adhesion molecule in liver cancer stem cells and nucleolin on the surface of cancer cells, respectively. Here, EPCAM is linked to cancer.